Platform Overview
Features
Cardiac AmyloidosisHeart FailureAortic StenosisPulmonary HypertensionStrain
Operations
Operational ImpactIT & ProcurementReimbursementsCore Lab SolutionsEHR Mining
Clinical Evidence
Our StoryCareersMedia Kit
NewsContact Us Login Book a Demo

Your AI Echo Copilot™

FDA-cleared, fully automated echocardiography analysis. From DICOM to structured report in seconds, not minutes.

Designed for echo labs where reporting time limits throughput and specialist availability limits access.

FDA 510(k) Cleared
CE Marked (Class IIb)
HIPAA & GDPR
Book a Demo Learn More
app.us2.ai/report/echo-analysis
How It Works

From Echo Scan to Structured Report, Automatically

Us2.ai connects to your ultrasound devices and PACS, processes echocardiograms in real time, and delivers standardized, clinician-ready reports. Unlike semi-automated tools that measure one parameter at a time, Us2.ai delivers a complete structured report: measurements, disease detection, and findings, all with zero clicks.

Zero-Click Analysis

No frame selection, no manual annotations. Studies are processed automatically from DICOM upload to final report. No additional clicks required.

Real-Time Processing

Results are ready before the patient leaves the exam room. Automated measurements and disease detection delivered in seconds, not minutes.

Fits Your Infrastructure

Cloud or on-premise. Connects to any ultrasound device, PACS, CVIS, or EMR. Deploy without changing your existing clinical workflow.

See Full Platform Overview
Featured In
Proven Results

Measurable Impact, Backed by Evidence

Peer-reviewed studies and clinical deployments show significant efficiency gains across echo labs.

0
Reduction in reporting time
Peer-reviewed study
0
Faster diagnosis time
Clinical deployment
Increased daily scan volume
Randomized controlled trial
35–40 → 10
min / study

University of Medicine & Pharmacy Hospital, HCMC — “AI can significantly shorten the diagnosis time… reduce the workload for medical staff, limit errors as well as save treatment costs.”

— Le Minh Khoi, Assoc. Prof. & Head of Cardiovascular Imaging

Us2.ai is making a difference in healthcare systems worldwide

0
Countries
0
Hospitals
0
Scans Analyzed
Who It's For

Built for Every Stakeholder in the Echo Workflow

Cardiologists

Guideline-directed, structured reporting with editable AI outputs and disease-specific indications for confident clinical decisions.

Sonographers

Automated measurements mean faster studies, less manual work, and reduced fatigue, giving sonographers more time focused on patients.

Core Labs

Standardized, automated parameters remove variability and improve quality consistency across every study.

Hospitals

Standardize echo reporting across your institution with cross-site consistency, centralized quality assessment, and compliance monitoring, all while scaling to handle higher patient volumes.

Patients

Shorter waiting times, faster examinations, and earlier identification of heart conditions support quicker referral to the right treatment pathway and better long-term outcomes.

First-of-its-Kind

AI-Powered Cardiac Amyloidosis Detection

Cardiac amyloidosis is one of the most under-diagnosed conditions in cardiology. Us2.ai is the first and only platform to combine deep learning pattern recognition with guideline-based echocardiographic measurements for automated detection. FDA cleared and CE marked.

Learn more about our approach →
Pattern Recognition Deep learning applied to standard apical four-chamber view
Guideline-Based Combines AI pattern detection with established measurement criteria
Regulatory Cleared FDA 510(k) cleared and CE marked for clinical use
Testimonials

Trusted by Healthcare Professionals Worldwide

Marianna Fontana, MD, PhD
Professor of Cardiology, National Amyloidosis Centre, University College London
Cardiac amyloidosis remains a frequently under-diagnosed condition with significant prognostic implications. Us2.ai's AI-based pattern recognition model, applied to a standard apical four-chamber view, provides a promising solution.
Jeremy Slivnick, MD
Assistant Professor, Division of Cardiovascular Medicine, The University of Chicago Medicine
Us2.ai's platform already provides powerful automated measurements that support the detection of cardiac amyloidosis. But this new deep learning approach moves beyond standard measurement workflows by enabling fast, fully automated detection.
Becky Schwaegler, BS, RDMS, RDCS (AE,PE), FASE
Cardiac Sonographer Specialist / Lead
From my personal experience, I have felt very fortunate to be able to use Us2.ai – a remarkable platform... I am truly amazed with its speed, overall accuracy and ease.
Ilya Karagodin, MD
General and Advanced Imaging Cardiologist, Endeavor Health, USA
This advanced technology leverages AI to deliver consistent and fast imaging analysis, empowering us to accelerate informed treatment decisions for our patients.
Nobuyuki Kagiyama, MD, PhD
Associate Professor, Dept. of Cardiovascular Biology and Medicine, Juntendo University
AI provides a consistent 'gold standard' that can be uniformly applied to all examinations, significantly reducing variability...
Deepak Borde, MD, DNB, FCA, FTEE
Cardiac Anesthesiologist, United CIIGMA Hospital, India
I can't take my eyes off those images, and I can't believe I could get them with ZERO CLICKS!
Le Minh Khoi, MD
Associate Professor, Head of Cardiovascular Imaging, University of Medicine and Pharmacy Hospital, Ho Chi Minh City
AI can significantly shorten the diagnosis time from 35-40 minutes to about 10 minutes. This helps reduce the workload for medical staff, limit errors as well as save treatment costs.
Sreekanth Vemulapalli, MD
Associate Professor of Medicine, Duke University
The US2 software could enable the use of echocardiography in screening or as a procedure at an accelerated pace and in a cost-effective manner.
Chris Mansi, MD, MBA
CEO, Viz.ai
We are proud to partner with Us2.ai to enhance and complement our comprehensive AI platform, tailoring it to cardiovascular needs, so that cardiologists and care teams can provide optimal care to more patients most efficiently.
Elad Walach
CEO, Aidoc
Our partnership with Us2.ai allows our health system partners to further expand the clinical value of AI to cardiac care. Health systems cannot work with thousands of AI point solutions for each service line. Our aiOS allows health systems to think strategically about AI and build an end-to-end intelligence layer across the health system.
Daniel Cehic, MBBS, MBA, FICOS, FCSANZ, FRACP
CMO, Advara HeartCare
David O'Donnell, MBBS, FRACP, FCSANZ
CEO, Advara HeartCare
Partnering with Us2.ai, we are excited to investigate how AI can enhance our diagnostic capabilities and optimize the experience and clinical outcomes for our patients.
Trust & Security

Enterprise-Grade Security and Compliance

GDPR & HIPAA Compliant

Protecting patient data with global privacy standards

ISO 27001:2022 Certified

Industry-leading information security practices

SOC 2 Type II

Proven security controls to keep your data safe

MDSAP Certified

Ensuring medical device safety and regulatory compliance

Visit Trust Center
Get Started

Book a Demo

Message Sent!

Thank you for reaching out. Our team will review your message and get back to you within 1-2 business days.

163 Tras Street #09-04, Lian Huat Building, Singapore 079024
+65 6232 7857
info@us2.ai